-
Products
-
Resources
-
Customer Service
-
About us
- Neurélux
-
Products
-
Resources
-
Customer Service
-
About us
Products
Resources
Customer Service
About us
Products
Resources
Customer Service
About us
Neurélux
Brain Wellness Device
Powered by HS FRAME™ · Non-contact · Silent · Home Use
KBSI & Gachon Univ. College of Medicine Exploratory Pilot (Mar 2026)
+1.835%
Hippocampus Volume Change
+1.798%
Cerebellum Volume Change
* Exploratory pilot data (small initial human study). Not a claim of medical treatment efficacy; follow-up studies are ongoing.
See the Neurélux Brain Wellness Device in action
Near-infrared light passes through the skull non-invasively to act on brain neurons
STEP 01
DNIR (800nm-band + 1000nm-band) near-infrared light penetrates the skull and brain tissue.
STEP 02
Cytochrome c oxidase (Complex IV) in neurons absorbs the photons.
STEP 03
Mitochondrial ATP synthesis is activated, supporting cellular energy metabolism.
STEP 04
Exploratory studies suggest possible benefits for cognitive function and brain conditioning.
* The above describes the mechanistic pathway currently under research. Medical efficacy has not been confirmed; follow-up clinical studies are ongoing.
HS FRAME's DNIR technology is the core technology unique to Neurélux among tPBM devices
PRIMARY
800nm
band
Primary absorption band of cytochrome c oxidase. Effectively reaches cortical tissue beneath the skull. HS FRAME™ DNIR ensures stable output throughout every session.
SECONDARY
1000nm
band
Longer wavelength increases the potential to reach deeper brain structures. HS FRAME™ DNIR technology supports consistent irradiation to deep structures such as the hippocampus.
Wavelength stability equals session reproducibility — consistent optical conditions every session
As a standard LED heats up during operation, its emission wavelength can shift slightly. In tPBM, wavelength stability is directly linked to session-to-session reproducibility. HS FRAME™ is a proprietary technology developed to structurally address this problem.
By integrating the LED chip, circuit, and heat sink into a single unified structure, thermal resistance of 1.75 K/W is achieved — a 37× improvement over conventional 65 K/W designs. Stable junction temperature ensures wavelength and output remain within specification throughout every session.
37×
Lower thermal resistance
(vs. 65 K/W conventional)
10×
Faster heat dissipation
Stable
Wavelength-stable output
maintained structure
2×
Extended device lifespan
Fanless
Silent operation
* Based on internal measurement data. Compared to conventional 65 K/W standard structure.
Two models to fit your purpose and space
DESK MODEL
Focused Care · Daily Wellness
STAND PRO MODEL
Full-brain Care · Premium
* Pricing and release schedule will be announced separately.
Building a stepwise clinical evidence base, starting from exploratory pilot data
Completed — Mar 2026
6-week exploratory pilot study collaboratively measured with the Korea Basic Science Institute (KBSI) and Gachon University College of Medicine. Observed volumetric changes in hippocampal and cerebellar regions.
Ongoing — 2026
In collaboration with an MRI AI diagnosis specialist company. SCI(E) journal paper in preparation. Accumulating neurophysiological mechanism data.
Planned — 2027
IRB-approved randomized controlled trial. MFDS IND application and medical device approval roadmap in progress.
Disclaimer: The fMRI pilot data currently disclosed represents exploratory early-stage human research results and does not constitute proof of medical treatment efficacy. Neurélux is currently in a pre-commercial stage as a brain wellness device and has not received medical device approval. Follow-up clinical studies are ongoing.
Transcranial photobiomodulation (tPBM) is the non-invasive application of near-infrared light to the scalp to stimulate brain cells. Light penetrates the skull and is absorbed by mitochondria in neurons, with potential to increase ATP production, reduce inflammation, and support cerebral blood flow. It is a non-contact, non-invasive, and drug-free approach to brain wellness.
A 6-week exploratory pilot study using Neurélux, conducted in March 2026 in collaboration with the Korea Basic Science Institute (KBSI) and Gachon University College of Medicine, measured brain volume changes via fMRI. Results showed hippocampus volume increased by +1.835% and cerebellum volume by +1.798%. These are preliminary, exploratory data from a small pilot cohort and are not proof of medical efficacy. A follow-up confirmatory RCT is being designed.
Three key differentiators: First, HS FRAME™ DNIR (800nm-band + 1000nm-band) — this technology is exclusive to Neurélux among home tPBM devices. Second, HS FRAME™ patented thermal management structurally maintains wavelength and output stability throughout every session. Third, Fanless design enables completely silent operation.
Neurélux is currently positioned as a brain wellness device and has not received medical device approval. Korea Lighting is pursuing a phased roadmap toward MFDS Class II medical device approval. At the current stage, it is positioned as a wellness device for general health management purposes.
Neurélux is currently in a pre-commercial stage. Release schedule and purchase/rental details will be announced separately. For advance inquiries, please use the contact form below.
We welcome inquiries regarding product launch notifications, clinical collaboration, and distribution partnerships.
Contact UsNeurélux is a transcranial photobiomodulation (tPBM) device developed by Korea Lighting Co., Ltd., powered by HS FRAME™ DNIR technology. Delivering stable irradiation across the 800nm-band and 1000nm-band near-infrared spectrum, it features non-contact, silent, Fanless operation.
Transcranial photobiomodulation (tPBM) is a research field exploring how near-infrared light, penetrating the skull, may act on neuronal mitochondria. Neurélux is currently under research and development as a non-invasive wellness device for cognitive function support and home brain care.
HS FRAME™ is a next-generation photosemiconductor packaging technology integrating LED chip, circuit, and heat sink in a unified structure, with 7-country patent registration complete. Korea Lighting has accumulated 11 billion KRW in R&D investment since founding in 2010, and has received the IR52 Jang Yeong-sil Award twice.